.
1548 financial statements
* Numbers in millions
Year |
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|
Capitalization * |
1 646 | 5 835 | 49 202 | 20 540 | 32 444 | 18 818 | 47 235 |
EV * |
1 542 | 5 699 | 49 078 | 20 056 | 32 212 | 18 237 | 18 237 |
Stock price ¤ |
1.38 | 3.5 | 28.7 | 11.46 | 17.5 | 9.9 | 24.85 |
Number of shares * |
1 193 | 1 667 | 1 714 | 1 792 | 1 854 | 1 901 | 1 901 |
EPS |
0,01 | 0,02 | 0,02 | 0,01 | -0,05 | -0,11 | -0,11 |
Revenue * |
87 | 115 | 153 | 231 | 273 | 390 | 390 |
Net income * |
18 | 26 | 26 | 21 | -97 | -205 | -205 |
Operating profit * |
11 | 26 | 44 | 9 | -123 | -193 | -193 |
Total liabilities * |
33 | 42 | 276 | 424 | 517 | 632 | 632 |
Net debt * |
-104 | -136 | -124 | -484 | -232 | -581 | -581 |
Total assets * |
182 | 226 | 504 | 917 | 889 | 1 447 | 1 447 |
Equity * |
149 | 184 | 228 | 493 | 372 | 816 | 816 |
Cash and investments * |
104 | 136 | 127 | 565 | 427 | 771 | 771 |
Over the past 10 years, the maximum capitalization of Genscript Biotech Corporation is 49 202, the minimum is 1 646. Maximum net income 26, Minimum net income -205. The maximum price of 1548 shares is 28.7, the minimum price is 1.38.
.
1548 valuation
Year |
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|
P/E |
94,02 | 222,98 | 1 883,46 | 968,15 | -334,78 | -91,82 | -230,47 |
P/B |
11,03 | 31,71 | 215,50 | 41,64 | 87,14 | 23,07 | 57,91 |
P/S |
18,98 | 50,86 | 322,32 | 88,91 | 118,69 | 48,21 | 121,01 |
E/P |
1% | 0% | 0% | 0% | 0% | -1% | 0% |
P/FCF |
134,92 | 240,20 | -4 640,35 | 95,18 | -218,49 | -124,54 | -312,62 |
.
1548 profitability
Year |
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|---|---|---|
ROE |
12% | 14% | 11% | 4% | -26% | -25% | |
ROA |
10% | 12% | 5% | 2% | -11% | -15% | |
ROIC |
8% | 14% | 19% | 1% | -19% | -17% |